ARTICLE | Company News
Allergan, The Centre for Applied Microbiology & Research deal
May 22, 2000 7:00 AM UTC
AGN received an exclusive license to commercialize CAMR technology that is based on modifying neurotoxins produced by Clostridium botulinum to treat acute and chronic pain. CAMR will receive up to £20...